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During prophase I of male meiosis, the sex chromosomes form a compact structure called XY body that associates with the nuclear
membrane of pachytene spermatocytes. Ret Finger Protein is a transcriptional repressor, able to interact with both nuclear matrix-
associated proteins and double-stranded DNA. We report the precise and unique localization of Ret Finger Protein in pachytene
spermatocytes, in which Ret Finger Protein takes place of lamin B1, between the XY body and the inner nuclear membrane. This
localizationofRetFingerProteindoesnotseemtobeassociatedwithO-glycosylationorsumoylation.Inaddition,wedemonstrate
that Ret Finger Protein contains an E3 ubiquitin ligase activity. These observations lead to an attractive hypothesis in which
Ret Finger Protein would be involved in the positioning and the attachment of XY body to the nuclear lamina of pachytene
spermatocytes.
Copyright © 2009 Isabelle Gillot et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
During meiosis, homologous recombination between chro-
mosomes is allowed by synapsis of chromosome’s pairs
during pachytene stage. At this stage, all the chromosomes
are attached to the nuclear membrane by their telom-
eres. In order to deal with asynchronous synapsis of the
XY chromosomes, mammals have adopted a strategy that
involves chromatin condensation and seclusion of the sex
chromosomes into a specialized and visibly distinct nuclear
territory, known as the XY body (see [1, 2] for review). After
early pachytene, the XY chromosomal pair becomes highly
condensed, transcriptionally silent, and positioned adjacent
to the nuclear envelope.
Localization of the condensed XY body to one part
of the nucleus suggests that a particular composition of
the nuclear matrix could be involved in the positioning
and/or attachment of the XY body or sex chromosomes
to the nuclear lamina [3, 4]. The nuclear lamina provides
an attachment site for chromatin and facilitates processes
associated with DNA replication and transcription. In germ
cells, lamin B1, as well as speciﬁc isoforms of lamin A/C, is
evidenced in the nuclear matrix [5, 6].
The precise molecular events underlying sex chromatin
condensation and meiotic inactivation of sex chromosomes
remain to be elucidated. However some hypotheses have
been advanced based on the presence or the absence of
speciﬁc proteins inside the XY body [2]. Matsuura et al. [7]
reported that SUMO-I and PIAS-y are found inside the XY
body and proposed that Ret Finger Protein (RFP) can also be
associatedwiththeXYbodyandcouldthenhavearoleinthe
silencing of sex chromosomes.
The initial interest in RFP arose from the demonstration
that it becomes oncogenic when fused with the RET tyrosine
kinase [8]. In healthy animals, RFP is highly expressed in
male germ cells, in particular in primary spermatocytes
and in round spermatids [9]. RFP is usually detected as
a 58kDa protein by western blot analysis. However, two
isoforms of RFP, 58kDa and 68kDa, can readily be detected
in testis [9, 10]. Tezel et al. [11] have shown that the 68kDa
isoform results from an O-glycosylation of RFP. Despite
extensive studies, the biological functions of RFP remain
unclear. It has been described as a nonspeciﬁc DNA-binding
protein strongly associated with the nuclear matrix [10].
RFP has also been shown to partially colocalize with PML
and Inf6 [12, 13]. RFP has been implicated in general2 International Journal of Cell Biology
transcriptional repression mechanisms, in particular when
it interacts with the Enhancer of Polycomb (EPC), Mi-2β
and histone deacetylase 1 (HDAC1) [14–16]. In somatic
cells, SUMO-I modiﬁcation of RFP induces its relocalization
into nuclear bodies reminiscent of the PML bodies and
strengthens its transcriptional repressor activity [7]. RFP
has also been proposed to repress transcriptional activity of
speciﬁc proteins such as Retinoblastoma protein or bHLH
transcription factors [17, 18]. However, the role of RFP
in meiotic cells remains unclear. Finally, RFP belongs to
the family of RING-B-Box-Coiled Coil-B30.2 proteins [19].
According to the International Mouse Genome Informatics
Committee, the proteins containing RING-B-Box-Coiled
Coil motif have been renamed TRIM proteins, and the name
of TRIM 27 was assigned to RFP [20, 21]. As a result of
numerous studies, it has been proposed that all the RING
ﬁnger containing proteins, as well as TRIM proteins, could
act as E3 ubiquitin ligases and be involved in proteasomal
degradation process (reviewed in [20, 22, 23]).
We report here the precise localization of RFP in
pachytene spermatocytes. We demonstrate that RFP exhibits
a unique and speciﬁc localization that may deﬁne the
positioning of the XY body. Moreover, as predicted by the
presence of a RING domain, we demonstrate that RFP
possesses an E3 ubiquitin ligase activity.
2.MaterialsandMethods
2.1. Cells and Virus Propagation. 15P-1 cells [24]w e r e
maintained at 32
◦C in DMEM media (Gibco: 41966-029)
supplemented with 10% Fetal Bovine Serum (FBS, Gibco:
10270-098) and 1/100 Penicillin/Streptomycin (P-S, Gibco:
15140-163).
Sf9 cells (BD Biosciences: 554762) were maintained in
TNM-FH media supplemented with 1/100 P-S as previously
described [25]. Baculoviruses were propagated, prepared,
andtitteredinSf9cellsasdescribedbythemanufacturer(BD
Biosciences).
Fractionation of germ cells from twenty B6D2F1 mice
by elutriation centrifugation was performed as previously
described [26] and the purity of each fraction was deter-
mined by DNA staining with DAPI. Fractions used were esti-
mated to contain more than 80% of puriﬁed spermatocytes,
round spermatids, or elongated spermatids.
2.2. Construction of Plasmids and Baculoviruses. Primers
RFPsense139 5  CCGGAATTCATGCCTGCGGCCCAG-
CCG and RFPrev569 5  CCGCTCGAGGCTGTGGTCGCG-
GTGCTC were used to amplify the RING-B-Box domain
of RFP from total testis cDNA. EcoRI/XhoI digested PCR
fragment was ligated in pGex4T-1 (Amersham Biosciences:
27-4580-01). Transformation of BL21 bacteria (Novagen:
69449) with the pGEX-RING-B-Box resulting plasmid was
used for the production of a GST-RING/RFP fusion protein.
MTS1-Mycbaculovirustransfervector,alreadydescribed
[27], is derived from pAcSG2 (BD PharMingen: 554769) and
contains the human cytomegalovirus promoter/enhancer
sequences (CMV) and an additional Myc tag.
RFPsense146StuI 5  GAAGGCCTCTCATGCCTGCGG-
CCCAG and RFPrev1733KpnI 5  CGGGGTACCGTCTAC-
GTTCACTTCCTCAC were used to amplify full-length RFP
coding sequence. StuI/KpnI PCR fragments were ligated in
MTS1-Myc resulting in MTS-Myc-RFP.
All constructions were veriﬁed by sequencing (ABI
PRISM 310 genetic analyzer, PerkinElmer Life Sciences).
Baculoviruses Bac-Myc-RFP encoding for Myc-RFP were
generated by cotransfecting Sf9 cells with linearized bac-
ulovirus DNA (BD BaculoGoldTM transfection Kit: 554740)
and MTS-Myc-RFP baculovirus transfer vector as described
by the manufacturer. In 15P-1 cells infected with the Bac-
Myc-RFP recombinant baculoviruses, CMV promoter drives
the expression of Myc-RFP.
2.3. Protein Puriﬁcation in Bacterial Cell System. BL21 bac-
t e r i a lc e l l st r a n s f o r m e dw i t hp G E Xv e c t o r sw e r ea m p l i ﬁ e d
at 37
◦C in LB medium supplemented with 0.1μMZ n 2+
and 50μg/mL ampicillin. At optical density 0.6–0.8, cells
were induced at 30
◦C by adding 1mM IPTG for two
hours. GST fusion proteins were puriﬁed using Glutathione
Sepharose 4B (Amersham Biosciences: 17-0756-01), eluted
with reduced glutathione (Sigma: G-4251), and dialyzed
against PBS (Phosphate-Buﬀered Saline pH 7.4) contain-
ing 1μMZ n S o 4 using disposable dialyzer (Sigma-Aldrich:
Z368385-10EA).
2.4. TPEN Treatment of GST-RING/RFP. For cation
chelation, GST-RING/RFP immobilized on Glutathione
Sepharose was incubated overnight at 4◦C, with 5mM
N,N,N
 ,N
 -tetrakis(2-pyridylmethyl)-ethylenediamine
(TPEN) (Sigma-Aldrich: 87641) or 1% ethanol (vehicle)
in 50mM Tris, pH 7.5. After extensive washes, one half of
the immobilized GST-RING/RFP was treated with 30μMo f
ZnCl2 for 45 minutes at room temperature. After washing,
samples were used for ubiquitination assays.
2.5. RFP Immunoprecipitation from Baculovirus-Infected
Cells. 15P-1 cells, seeded 15 to 18 hours before infection at
80%–90% conﬂuency, were exposed in TNM-FH media to
1 plaque-forming units per cell of wild type or Bac-Myc-
RFPrecombinantbaculoviruses.After2hours,theinoculum
was replaced by fresh DMEM medium containing 5mM
sodium butyrate (Sigma-Aldrich: B5887) and cells were
incubated at 32
◦C for 72 hours. Cells were lysed in a buﬀer
containing50mMTris-HCl(pH8.0),150mMNaCl,1%NP-
40, and EDTA-free “complete” protease inhibitors (Roche:
1873580) sonicated brieﬂy, and centrifuged for 10 minutes
at 13,000rpm at 4◦C (Biofuge pico, 3325 Heraeus rotor;
Sorvall, Norwalk, Conn.). Supernatant was used for RFP
immunoprecipitation using a rabbit polyclonal antibody
to RFP (IBL Japan: JP 18791) according to the supplier’s
instructions. After washing, immunoprecipitated RFP was
used for ubiquitination assays.
2.6. Western Blots. Elutriated germ cells [26]w e r el y s e d .P r o -
teinconcentrationwasevaluatedusingaBradfordassay(Bio-
Rad: 500-0006); 20μg of proteins per lane were subjectedInternational Journal of Cell Biology 3
to SDS Page electrophoresis (8%) and blotted on PVDF
membrane. Rabbit polyclonal antibody to RFP (IBL Japan:
JP 18791) and mouse anti-rabbit peroxidase-conjugated
antibody (Sigma-Aldrich: a2074) were used at 1 : 200
dilution and 1 : 10000 dilution, respectively. Immunoblots
were done through enhanced chemiluminescence detection
(AmershamBiosciences:RPN2132).ECLblotswereanalyzed
using a Fuji Film Intelligent Dark box (LAS-3000) and the
associated computer programs (Image Reader Las-3000 and
Multi-Gauge V2.3).
2.7. In Vitro Substrate-Independent Polyubiquitination. In
vitro polyubiquitination assays were performed as described
in Hagglund et al. [28], in ubiquitination buﬀer (50mM
Tris, pH 7.5, 2.5mM MgCl2, 0.5mM DTT) containing
40ng of E1 (Calbiochem: 662070), 40ng of one E2 (Biomol
Aﬃniti, [His6]-UbcH1 (uw9020); [His6]-UbcH2 (uw9025);
[His6]-UbcH3 (uw8730); [His6]-UbcH5a (uw9050); [His6]-
UbcH5b (uw9060); [His6]-UbcH5c (uw9070); [His6]-
UbcH6 (uw8710); [His6]-UbcH7 (uw9080); [His6]-
UbcH10 (uw8715)) or [His6]-HR6A or [His6]-HR6B both
produced in the laboratory, 2μg of biotinylated ubiquitin
(Biomol Aﬃniti: uw8705), 0.2mM ATP, 1mM creatine
phosphate (Calbiochem: 2380), and 15 units of porcine
heart creatine phosphokinase (Calbiochem: 238395) in
30μL ﬁnal volume. When indicated, the reaction was
performed in absence of ATP. Immunoprecipitated RFP
and either ﬁve μg of GST or GST-RING/RFP recombinant
protein were added to the reaction mixture and incubated
at 37
◦C for 90 minutes. Reactions were stopped with
4X Laemmli buﬀer and subjected to SDS-Page analysis.
Membranes were rinsed and blocked in PBS, 0.1% BSA, and
0.1% Tween 20 and reacted 1 hour at room temperature with
0.02 unit/mL of streptavidin peroxidase (Roche: 1089153).
Biotinylated ubiquitin conjugates were revealed after ECL.
Membranes were exposed on Kodak ﬁlm (X-Omat LS ﬁlm:
ref F0899-50EA).
2.8. Immunoﬂuorescence Analysis. Immunoﬂuorescence la-
beling has been performed on testis frozen sections, on total
germ cell preparations, or on elutriated germ cells prepared
as previously described [26].
C e l l sw e r eﬁ x e di nc o l de t h a n o l( −20
◦C )f o r1h o u r
before a 30-minute blocking step in PBS containing 1% BSA
(Sigma: A-4503) and 20% normal human serum.
Colabeling experiments have all been performed in a
sequential manner according to the same protocol. Anti-
bodies were diluted in PBS containing 1% BSA and 2%
normal human serum. After each antibody incubation,
samples were washed three times with PBS containing 1%
BSA. Primary speciﬁc antibodies were incubated overnight
at 4◦C and the secondary antibody was added for 1 hour
at room temperature. The second speciﬁc antibody was
then incubated for 2 hours at room temperature and the
secondary antibody was added for 1 hour. After a ﬁnal wash
in PBS, slides were mounted in Vectashield reagent with
DAPI (Vector Laboratories, Inc., Burlingame).
Thespeciﬁcantibodieswere:agoatpolyclonalIgGLamin
B1 antibody (Santa Cruz Biotechnology: M-20, sc-6217); a
rabbit polyclonal RFP (IBL Japan: JP 18791) antibody; a
mouse monoclonal SUMO-I antibody (Zymed laboratories:
33-2400), a mouse IgG anti phosphohistone H2AX antibody
(Stress gen Bioreagents corp., Canada: KAM-CC255) respec-
tively diluted at 1 : 80, 1 : 150; 1 : 400 and 1 : 800.
The secondary antibodies (dilution 1 : 400) were: a Cy-
3c o n j u g a t e da ﬃnity Pure donkey anti-goat IgG (Jackson
Laboratories: 705-165-147); a goat anti-rabbit Alexa 516 and
a goat anti-mouse Alexa 546 antibodies (Molecular Probes,
Oregon: A11035 and A11030).
2.9. Image Analysis. Image acquisition (Objective 60 × 1.4
Uplanapo)anddeconvolutionusingtheconstrainediterative
algorithm (Softworx 2.5) was performed with Applied
Precision DeltaVision system (Applied Precision, Issaquah,
WA) built on an Olympus IX-70 base.
In Figures 4(a) and 4( b )i m a g e sw e r em a d eb yt h e
sum of the intensities of three consecutive images taken
in Z position (0.15nm interval) in each channel. Treat-
ment was performed using ImageJ NIH software. The 3D
reconstruction (Figures 4(c), 4(d), and 4(e)) has been made
with 30 consecutives images taken in Z position and the
reconstruction is made using Volocity software and Image
plugin Volume Viewer (Kai Uwe Barthel).
2.10. Immunogold Analysis. Samples ﬁxation, ultrathin sec-
tions and immunogold labeling was performed as previously
described [29]. Anti-RFP and anti-SUMO-I antibodies were
diluted 1 : 100 in PBS; 1% BSA; 1% NGS. Colloidal gold
conjugated anti-rabbit IgG antibodies (15nm) and colloidal
gold conjugated anti-mouse IgG antibodies (10nm) were
diluted 1/20 in PBS 0.01% ﬁsh-skin gelatin. Preparations
were observed with a Philips CM12 electron microscope
operating at 80kV. No signal was observed when the ﬁrst
antibody was omitted.
3. Results
3.1. RFP Exhibits Various Localizations in Meiotic and
Postmeiotic Germs Cells. RFP localization in mouse male
germ cells, and in particular in pachytene spermatocytes, has
previously been described as a perinuclear cap structure [9].
Immunolabeling of RFP in testis sections corresponding to
stages late VIII and IX of mouse spermatogenesis (Figures
1(a)–1(c)) revealed at least two diﬀerent localizations for
RFP in germ cells: a thin cap-like structure forms next to the
nucleus of meiotic germ cells which then seems to condense
to a spot in later stages of spermatogenesis. Optical and
electronic analysis indicate that these foci of RFP are then
found in residual bodies (data not shown).
Two isoforms of RFP 58kDa and 68kDa have previously
been described in testis [9]. Tezel et al. [11] have shown
that the 68kDa form resulted from an O-glycosylation of
RFP. Considering the speciﬁc localization of RFP protein in
the nuclear matrix of pachytene spermatocyte, we checked4 International Journal of Cell Biology
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Figure 1: Distribution of RFP isoforms in meiotic and postmeiotic
germ cells. (a)–(c) Immunoﬂuorescent labeling of RFP on testis
sections corresponding to late VIII and IX stages of mouse
spermatogenesis. Sequential optical layers are separated by 4μm
from each other. RFP positive signals (green) are detected either as
a cap-like structure localized at the border of the nucleus (DAPI,
blue) in pachytene spermatocyte (mainly seen in (a)) or as a dot in
post meiotic germ cells and in residual bodies (mainly seen in (b)
and(c)).Scalebar,25μm.(d)20μgofproteinspreparedfrom80%–
90% pure elutriated preparations of pachytene spermatocytes (ps),
roundspermatids(rs),andelongatedspermatids(es)wereanalyzed
by western blotting with rabbit anti-RFP polyclonal antibody. Sizes
(kDa) are indicated on the left side and the two RFP isoforms (58
and 68kDa) are indicated by the arrows. A nonrelevant band was
used as loading control (lower part).
thepossiblerelationshipbetweenthisposttranslationalmod-
iﬁcation and the localization of RFP. We investigated the
respective distribution of the 58kDa and 68kDa isoforms
in elutriated germ cell populations (Figure 1(d)). Our results
indicated that maximal RFP expression is found as expected
inroundspermatids[9].However,bothisoformswerefound
in pachytene spermatocytes, in round spermatids, and in
elongated spermatids. Furthermore, the ratios between the
two isoforms were equivalent in these diﬀerent germ cell
populations (53.43%/46.57% in pachytene spermatocyte,
51.68%/48.32% in round spermatids and 49.88%/50.12%
in elongated spermatids for the ratio of 58kDa/68kDa
isoform, resp.). Relative distribution of each RFP isoform
does not show any clear relationship between the level of O-
glycosylation and the localization of RFP in pachytene cells.
3.2. RFP Deﬁnes a Region Underlying the XY Body in
Pachytene Spermatocyte. It has been reported that PIASy
and SUMO-I localizes within the XY body, an intranuclear
(a)
(b)
(c)
(d) (e)
(f) (g)
Figure 2: RFP deﬁnes a region underlying the XY body in
pachytene spermatocyte. Immunoﬂuorescent labeling of RFP on
seminiferoustubule((a),bar,20μm)orinpachytenespermatocytes
(b), (c). Coimmunolocalization of RFP and γH2AX (d), (e) and
RFP and SUMO-I (f), (g) in pachytene spermatocytes (bar, 8μm).
In pachytene spermatocytes, RFP immunoﬂuorescent staining
(green) is condensed in a cap-like structure localized at the border
of the nucleus (DAPI, blue). The XY body is visualized either by
γH2AX or SUMO-I antibodies (red). Superposition of labeling is
never observed. The lace structure of RFP is evidenced when seen
full face (g).
structureofthemeiotic spermatocytes.Basedon monolabel-
ing immunostaining experiments, it has been proposed that
RFP was located at the same place [7] .I no r d e rt oe x a m i n e
the precise localization of endogenous RFP compared to
XY body markers, such as SUMO-I and γH2AX proteins
[30, 31], we have performed coimmunolabeling experiments
at the structural and the ultrastructural levels on meiotic
spermatocytes. We demonstrate that RFP localized as a small
cap at the periphery of the pachytene spermatocyte nuclei
(Figure 2). Colabeling experiments made (Figures 2(d) and
2(e)) indicated that RFP and γH2AX proteins did notInternational Journal of Cell Biology 5
colocalize but rather deﬁned two diﬀerent domains around
and within the XY body. Speciﬁcally, γH2AX is detected
inside the XY body and RFP is a distinct layer adjacent to the
XY body, on the side facing the nuclear membrane. These
results were conﬁrmed using anti-RFP and anti-SUMO-I
antibodiesgivingasimilarpattern(Figures2(f)and2(g)).To
our knowledge, RFP is the only protein that has been shown
to exhibit such a particular localization.
Electron microscopy analysis of immunogold labeling,
performed on testis sections using anti-RFP and anti-
SUMO-I antibodies, conﬁrmed that the two proteins were
very closely apposed but did not colocalize within sperma-
tocyte nuclei (Figure 3). In order to obtain semiquantitative
data, we have evaluated the number of 15nm gold beads
(corresponding to RFP) and the number of 10nm gold
beads (corresponding to SUMO) in Figure 3.T oc o m p a r e
the localization of SUMO and RFP, we have evaluated the
number of gold beads located in the nucleus and in the XY
body. In Figure 3(a), nuclear surface has been evaluated to
59.48μm2 and the surface of the XY body to 2.68μm2.B y
counting the beads in the nucleus, we found a concentration
of 0.25 beads/μm2 for SUMO labeling and of 0.17 beads/μm2
for RFP labeling. Within the XY body, we have obtained
9.32 beads/μm2 for SUMOlabeling and 0 beads/μm2 for RFP
labeling.ComparableresultswereobtainedwhenFigure 3(b)
was analyzed in the same way. Moreover, in Figure 3(a),
the total length of nuclear envelope has been evaluated to
23.40μm and the membrane facing the XY body to 2.75μm.
Three 15nm gold beads have been found localized at the
nuclear membrane, all of them facing the XY body. The same
analysis was performed on Figure 3(b). Once again, 15nm
gold beads have been found only on the nuclear membrane
facing the XY body. So, these observations conﬁrm that RFP
is localized at the border of the nucleus facing the XY body,
while SUMO-I is inside the nucleus, associated with the XY
body. These results were summarized in Figure 3(e).
3.3. RFP Takes Place of Lamin B1 in Region of the Nuclear
MembraneAdjacenttotheXYBody. Wehavenoticedthatthe
labelingofthenuclearmembraneofpachytenespermatocyte
with an anti-lamin B1 antibody is interrupted in a region
reminiscent of the size and the position of RFP and XY
body [5]. Colabeling experiments using total germ cell
preparation, anti-lamin B1 and anti-RFP antibodies showed
that RFP accumulated in a region where lamin B1 was
almost completely absent (Figures 4(a) and 4(b)). After
deconvolution and 3D reconstruction, we visualized RFP
labeling as a disc inside the nuclear matrix (Figures 4(c)–
4(e)). When colabeling experiments were done with lamin
B1 antibody and either SUMO-I or γH2AX antibodies,
we could conﬁrm that this region of the nuclear envelope
adjacent to the XY body was devoid of lamin B1 labeling
(data not show). According to our results, we conclude
that in the nuclear lamina of pachytene spermatocyte, the
absence of lamin B1 could be involved in the speciﬁc
localization of RFP adjacent to the XY body, and thus,
RFP could provide a speciﬁc attachment point for sex
chromosomes.
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Figure 3:SubcellularlocalizationofRFPandSUMO-Iinpachytene
spermatocyte nucleus. (a), (b) Overviews of pachytene cells in
adult mouse testis (bar, 4μm). XY body (xy) in the nucleus (n) is
underlined by the dotted line (c, cytoplasm). The indicated part of
the XY body ( ) is enlarged in panels (c) and (d), respectively.
(c), (d) RFP and SUMO-I coimmunolabeling detected using gold
particles of two diﬀerent sizes: 15nm for RFP and 10nm for
SUMO-1 (bar, 160nm). RFP (r) is signiﬁcantly concentrated at
the border of the nucleus adjacent to the XY body labeled by
SUMO-I (s). (e) Nucleus, XY body, and nuclear membrane have
been schematized respecting relative size (excepted for nuclear
membrane). Mean of beads count is indicated in the correspond-
ing area (nm, nuclear membrane facing the XY body, xy: XY
body).
3.4. RFP Has an E3 Ubiquitin Ligase Activity Associated
with Its RING Domain. In somatic cells, RFP has been
involvedintranscriptionalregulation.However,regardingits
main localization in meiotic and postmeiotic germ cells, we
looked for another function for RFP. RFP contains a RING
domain and RING ﬁnger proteins have been proposed to
be involved in degradation via the proteasome [28, 32, 33].6 International Journal of Cell Biology
(a)
(b)
(c)
(d)
(e)
Figure 4: Relationship between XY body, RFP, and nuclear
matrix in pachytene spermatocyte. Coimmunoﬂuorescent labeling
of lamin B1 (green) with RFP (red). (a), (b) At this cell stage,
RFP takes place of lamin B1 along the border of the nucleus
(DAPI, blue; bar, 8μm). (c)–(e) Data presented as volumes within
a 3D-(xyz)-space reconstructed from an RGB image stack. The
three dimensions are represented by oriented arrows (x: yellow, y:
white, and z: red arrows), considering xyz reference positions taken
in (c).
We ﬁrst tested the ability of an Myc-tagged RFP to pro-
mote an in vitro substrate-independent polyubiquitination
[28]. As shown in Figure 5(a), a dark smear, characteristic
of polyubiquitination, can be observed with speciﬁc E2
enzymes such as UbcH1, UbcH5A, 5B, 5C, UbcH6, and
HR6B.
Using a GST-RING/RFP fusion protein, we demonstrate
that the RING domain isolated from RFP contained the E3
ubiquitin ligase activity. This activity was strictly dependent
of ATP hydrolysis (Figure 5(b)). The mandatory presence of
Zn2+ wasdemonstratedbyusingTPEN,achelatorofdivalent
cations, which abolished the E3 activity (Figure 5(c),l e f t
panel). As expected, after readdition of an excess of Zn2+,
the GST-RING/RFP retrieved its polyubiquitination activity
(Figure 5(c), right panel). Control treatments with vehicle
only or vehicle plus Zn2+ did not aﬀect the E3 activity of the
GST-RING/RFP protein (data not shown).
4. Discussion
We report here that in pachytene spermatocytes, RFP deﬁnes
a precise and restricted region of nuclear matrix that
correlates with the position of the XY body. This obser-
vation is supported by colabeling experiments using both
deconvolution and electron microscopy. To our knowledge,
the localization of RFP, associated with the nuclear matrix
in a region juxtaposed to the XY body but not within, is
unique in regard to the XY body. Of the lamins expressed
in somatic cells, lamin B1 is the only one that could be
detected in spermatocytes [5, 6]. Colabeling experiments
using anti-lamin B1 and anti-RFP antibodies indicate that
RFP occupied a region in the nuclear matrix, facing the XY
body and devoided of lamin B1. Regarding the ability of
RFP to interact with double-strand DNA and with nuclear
matrix proteins [10], our data suggest that RFP could be
involved in both positioning of the XY body in pachytene
matrix spermatocyte and attachment of this structure to
ar e g i o no ft h en u c l e a re n v e l o p em a t r i xd e v o i do fl a m i n
B1. Whether this is mediated through strong association of
RFP with other nuclear lamins or other proteins present
in the XY body remains to be determined. However, it is
unknown whether the localization of RFP is causative of XY
body localization or is the result of the apposition of the XY
body close to the nuclear membrane. Moreover, one cannot
exclude that RFP removes lamin B1 from the region of the
nuclear matrix where XY body attaches, possibly through its
potential E3 ubiquitin ligase activity. All these hypotheses
should be tested in future studies to better understand the
underlying mechanisms.
Neither O-glycosylation nor sumoylation of RFP seem
to be associated with its speciﬁc localization in pachytene
spermatocytes. Indeed, RFP (58kDa) and O-glycosylated
RFP (68kDa) are evidenced at equivalent ratios in meiotic
and postmeiotic germ cells (Figure 1(d)). Matsuura et al.
[7] have reported that overexpression of SUMO-I in cell
culture leads, in somatic cells, to the appearance of a
90kDa sumoylated RFP. They also have proposed that RFP
sumoylation could be involved in the localization of RFP in
pachytene spermatocytes. However, we did not detect the
described 90kDa SUMO-I-RFP reactive band on western
blot analysis performed on extracts enriched in pachytene
spermatocytes (Figure 1(d)). Moreover, our results indicate
that SUMO-I and RFP were closely located in spermatocytes
but did not colocalize in the XY body (Figures 2 and 3).
The results reported here showed that RFP is able to
act as an E3 ubiquitin ligase with a series of E2s such as
UbcH1, UbcH5A, 5B, 5C, UbcH6, and HR6B. This activity
is exerted by the RING-B-Box domain and requires both
ATP and Zn2+. HR6B has been described to be required for
correct spermatogenesis and to be localized in the XY body
[34, 35]. We propose that a functional interaction between
RFP and HR6B could account for an essential role of RFP
during spermatogenesis. These hypotheses have to be further
investigated in vivo and yeast double-hybrid experiments
are currently under way in our laboratory to test a possible
interaction between RFP and HR6B.
Like RFP, other E3 proteins such as RNF4, BRCA1, and
ICP0 have also been initially described for their broad eﬀect
on the cellular transcription activity [28, 32, 33]. It is then
interesting to note that, in somatic cells, these proteins, as
well as RFP and polyubiquitinated products, colocalize with
PML bodies and are able to self-assemble in such structures
[12, 25, 36, 37]. We have demonstrated that RFP proteinsInternational Journal of Cell Biology 7
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Figure 5: RFP has an E3 ubiquitin ligase activity. (a)–(c) Streptavidin peroxidase revelation of substrate-independent in vitro ubiquitination
reactionsusingimmunoprecipitatedRFP(a)orGST-RING-B-boxofRFP(GST-RING/RFP)(b),(c)aspotentialE3ubiquitinligaseenzyme.
Dark smears and signals higher than the biggest protein in the assay (monoubiquitinated E1 enzyme indicated by the asterisk) reﬂected
polyubiquitinated products. E2 enzymes are indicated on the top part of each ﬁgure. M: master mix containing all the components of
the system except E2 enzymes. Sizes (kDa) are indicated. (a) RFP protein immunoprecipitated from 15P-1 cell overexpressing Myc-RFP.
Polyubiquitination is observed when UbcH1, UbcH5a, 5b, 5c, UbcH6, or HR6B are used as E2 enzymes. (b) Reactions are performed in
presence or in absence of ATP. As expected mono- and poly-ubiquitinations are only observed in presence of ATP. (c) Prior to the substrate-
independent in vitro ubiquitination reaction, GST-RING/RFP was pretreated with TPEN (left panel) in order to chelate Zn2+ and destroy
RING ﬁnger architecture, or pretreated with TPEN, washed, and incubated with an excess of Zn2+ (right panel). As expected, when GST-
RING/RFP was treated with TPEN, only mono-ubiquitination can be observed (left panel) and incubation of TPEN treated GST-RING/RFP
with an excess of Zn2+ restores E3 ubiquitin ligase activity (right panel).
assemble as a cap in the nuclear envelope matrix, facing the
XY body. Later in spermatogenesis, RFP condenses as a spot
inroundspermatidsandthesefociaresubsequentlyfoundin
residual bodies, evocating a degradation process (Figure 1).
One can postulate that these foci structures result from RFP
self-assembly. These observations imply that RFP persists
through spermatogenesis and is probably polyubiquitinated
and degraded. We propose that RFP acts as an E3 ubiquitin
ligase, in addition to its previously described role as tran-
scriptional regulator in somatic cells [17, 18]. One attractive
hypothesis could be that RFP, via its E3 ubiquitin ligase
activity, might be involved in the release of XY body from
the nuclear matrix when pachytene spermatocytes progress
through meiotic prophase I. Whether the RFP containing
foci structures are the cause or the consequence of XY body
release remains to be determined.
It is also interesting to consider the link between PML
bodies and XY bodies. We know that both structures
share common proteins, for example, PML, DAXX, BRCA1,
SUMO-I, and γH2AX, involved in polyubiquitination pro-
cesses and are sites where transcriptional repression can be
established and maintained [25, 31, 38]. So, some of these
proteins are able to establish and maintain transcriptional
repression by sequestrating transcriptional regulators far
away from their targets [25, 38]. Therefore, one might
postulate that, in meiotic cells, RFP could interact with
transcriptional regulators and that these interactions could
play a role in the transcriptional silencing of the XY body
through RFP E3 activity.
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